European Archives - Page 542 of 899 - European Medical Journal

3rd December 2018

Realising the Full Potential of Biosimilars: Interviews with Three Key Opinion Leaders

These valuable insights were obtained from a series of interviews conducted between 19th September and 8th October 2018 by the European Medical Journal…

EMJ Oncology 6 [Suppl 2] 2018

These valuable insights were obtained from a series of interviews conducted between 19th September and 8th October 2018 by the European Medical Journal…

Innovate to elevate HCP engagement

The regulatory ecosystem of the pharmaceutical industry and people’s decreasing attention spans is proving a complex reality for marketers that has provided an imperative to innovate.

Adherence: a bespoke regime

What helps people to stick to their medication regimes, and how can pharma begin to recover their revenue as well as striving for better health outcomes?

29th November 2018

ProbeFix: Continuous Ultrasound Imaging and Improved Ergonomics

Working in the medical sector, whether as a nurse, researcher, or doctor, is often physically demanding. Healthcare workers are reported to sustain…

28th November 2018

An Interview with Daniel De Schryver from Janssen

An interview with Daniel De Schryver, Patient Engagement & Advocacy Lead, EMEA, Janssen Pharmaceutical Companies of Johnson & Johnson at the eyeforpharma Patient Summit, Europe. Daniel talks about overcoming fear to create a genuine dialogue that will make better solutions for patients and how his past experiences have helped shape his leadership today.

27th November 2018

Focus on Family: Family is the Key for Detection, Prevention, and Management of Diabetes! A World Diabetes Day Message

In 2017, the International Diabetes Federation (IDF)1 reported that 425 million adults have diabetes worldwide, and India alone has 73 million adults…

26th November 2018

Screening Programmes Improve Chances of Survival in Breast Cancer Patients

Debate has been ongoing for some time in the medical community as to whether screening programmes for breast cancer have any significant impact on the…

26th November 2018

Universal Blood Test for Cancer Under Development

Diagnosing cancer at an early stage is acknowledged as one of the best ways to achieve the best possible outcome for patients. With the incidence of…

23rd November 2018

An Interview with Asad Mohsin Ali from Ipsen

An interview with Asad Mohsin Ali, General Manager UK and Ireland, Ipsen, who talks about how pharmaceutical companies can add value and why market access is becoming a hot topic.